OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Safety and Clinical Effects of Mesenchymal Stem Cells Secreting Neurotrophic Factor Transplantation in Patients With Amyotrophic Lateral Sclerosis
Panayiota Petrou, Yaël Gothelf, Zohar Argov, et al.
JAMA Neurology (2016) Vol. 73, Iss. 3, pp. 337-337
Open Access | Times Cited: 280

Showing 1-25 of 280 citing articles:

Challenges and advances in clinical applications of mesenchymal stromal cells
Tian Zhou, Zenan Yuan, Jianyu Weng, et al.
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 475

Challenges and Controversies in Human Mesenchymal Stem Cell Therapy
Barbara Łukomska, Luiza Stanaszek, Ewa Zuba‐Surma, et al.
Stem Cells International (2019) Vol. 2019, pp. 1-10
Open Access | Times Cited: 467

Biological functions of mesenchymal stem cells and clinical implications
Abderrahim Naji, Masamitsu Eitoku, Benoı̂t Favier, et al.
Cellular and Molecular Life Sciences (2019) Vol. 76, Iss. 17, pp. 3323-3348
Closed Access | Times Cited: 459

Regenerative Capacity of Adipose Derived Stem Cells (ADSCs), Comparison with Mesenchymal Stem Cells (MSCs)
Loubna Mazini, Luc Rochette, Mohamed Amine, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 10, pp. 2523-2523
Open Access | Times Cited: 349

Immune dysregulation in amyotrophic lateral sclerosis: mechanisms and emerging therapies
David R. Beers, Stanley H. Appel
The Lancet Neurology (2019) Vol. 18, Iss. 2, pp. 211-220
Closed Access | Times Cited: 293

Amyotrophic Lateral Sclerosis: An Update for 2018
Björn Oskarsson, Tania F. Gendron, Nathan P. Staff
Mayo Clinic Proceedings (2018) Vol. 93, Iss. 11, pp. 1617-1628
Open Access | Times Cited: 292

Mesenchymal Stem Cells for Neurological Disorders
A Andrzejewska, Sylwia Dabrowska, Barbara Łukomska, et al.
Advanced Science (2021) Vol. 8, Iss. 7
Open Access | Times Cited: 276

Amyotrophic lateral sclerosis: a neurodegenerative disorder poised for successful therapeutic translation
Richard J. Mead, Ning Shan, H. Joseph Reiser, et al.
Nature Reviews Drug Discovery (2022) Vol. 22, Iss. 3, pp. 185-212
Open Access | Times Cited: 269

Engineering the next generation of cell-based therapeutics
Caleb J. Bashor, Isaac B. Hilton, Hozefa S. Bandukwala, et al.
Nature Reviews Drug Discovery (2022) Vol. 21, Iss. 9, pp. 655-675
Open Access | Times Cited: 260

Mesenchymal Stromal Cell Therapeutic Delivery: Translational Challenges to Clinical Application
Henry W. Caplan, Scott D. Olson, Akshita Kumar, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 248

Clinical application of mesenchymal stem cell in regenerative medicine: a narrative review
Ria Margiana, Alexander Markov, Angelina Olegovna Zekiy, et al.
Stem Cell Research & Therapy (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 233

Oxidative Stress in Ageing and Chronic Degenerative Pathologies: Molecular Mechanisms Involved in Counteracting Oxidative Stress and Chronic Inflammation
Thobekile S. Leyane, Sandy Winfield Jere, Nicolette N. Houreld
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 13, pp. 7273-7273
Open Access | Times Cited: 231

Concise Review: Mesenchymal Stem Cells in Neurodegenerative Diseases
Rotem Volkman, Daniel Offen
Stem Cells (2017) Vol. 35, Iss. 8, pp. 1867-1880
Open Access | Times Cited: 202

Beneficial effects of autologous mesenchymal stem cell transplantation in active progressive multiple sclerosis
Panayiota Petrou, Ibrahim Kassis, Netta Levin, et al.
Brain (2020) Vol. 143, Iss. 12, pp. 3574-3588
Open Access | Times Cited: 165

Regenerative Stem Cell Therapy for Neurodegenerative Diseases: An Overview
Farzane Sivandzade, Luca Cucullo
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 4, pp. 2153-2153
Open Access | Times Cited: 148

Preclinical efficacy and clinical safety of clinical‐grade nebulized allogenic adipose mesenchymal stromal cells‐derived extracellular vesicles
Mengmeng Shi, Qingyuan Yang, Antoine Monsel, et al.
Journal of Extracellular Vesicles (2021) Vol. 10, Iss. 10
Open Access | Times Cited: 141

Clinical utility of mesenchymal stem/stromal cells in regenerative medicine and cellular therapy
Vitali Maldonado, Neel Patel, Emma E. Smith, et al.
Journal of Biological Engineering (2023) Vol. 17, Iss. 1
Open Access | Times Cited: 53

Mechanical Thrombectomy Global Access For Stroke (MT-GLASS): A Mission Thrombectomy (MT-2020 Plus) Study
Kaiz Asif, Fadar Oliver Otite, Shashvat M. Desai, et al.
Circulation (2023) Vol. 147, Iss. 16, pp. 1208-1220
Open Access | Times Cited: 51

Mesenchymal stem cell secretome and extracellular vesicles for neurodegenerative diseases: Risk-benefit profile and next steps for the market access
Lorella Giovannelli, Elia Bari, Claudio Jommi, et al.
Bioactive Materials (2023) Vol. 29, pp. 16-35
Open Access | Times Cited: 49

ALS Pathogenesis and Therapeutic Approaches: The Role of Mesenchymal Stem Cells and Extracellular Vesicles
Roberta Bonafede, Raffaella Mariotti
Frontiers in Cellular Neuroscience (2017) Vol. 11
Open Access | Times Cited: 171

Mammalian MSC from selected species: Features and applications
Christiane Uder, S Brückner, Sandra Winkler, et al.
Cytometry Part A (2017) Vol. 93, Iss. 1, pp. 32-49
Open Access | Times Cited: 155

Functional role of mesenchymal stem cells in the treatment of chronic neurodegenerative diseases
Debora Lo Furno, Giuliana Mannino, Rosario Giuffrida
Journal of Cellular Physiology (2017) Vol. 233, Iss. 5, pp. 3982-3999
Closed Access | Times Cited: 154

Intranasal administration of exosomes derived from mesenchymal stem cells ameliorates autistic-like behaviors of BTBR mice
Nisim Perets, Stav Hertz, Michael London, et al.
Molecular Autism (2018) Vol. 9, Iss. 1
Open Access | Times Cited: 145

Page 1 - Next Page

Scroll to top